Related Experiment Video
Updated: Oct 16, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Diagnostic yield from routine metabolic screening tests in evaluation of global developmental delay and intellectual
Hilary Vallance1, Graham Sinclair1, Bojana Rakic1
1Department of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, British Columbia.
Insights
Expanding metabolic testing to community pediatricians did not increase diagnoses of inborn errors of metabolism (IEM). A revised test panel is recommended for children with global developmental delay, intellectual disability, or red flag symptoms.
Area of Science:
- Biochemistry
- Pediatrics
- Genetics
Background:
- Global developmental delay and intellectual disability (GDD/ID) affect 3% of children.
- Inborn errors of metabolism (IEM) are rare causes of GDD/ID, but early diagnosis improves outcomes.
- A first-tier metabolic test panel was implemented for community pediatricians in British Columbia in 2012.
Purpose of the Study:
- To evaluate the diagnostic yield of first-tier metabolic testing for IEM.
- To compare testing results before and after implementation in community pediatric settings.
Main Methods:
- Retrospective review of metabolic testing data.
- Analysis of diagnostic yield from 2006-2012 (pre-implementation) and 2013-2019 (post-implementation).
Main Results:
- Diagnostic yield for IEM was 0.91% pre-implementation and 0.25% post-implementation.
- Creatine metabolism disorders and organic acidurias were most common.
- No diagnoses were made using acylcarnitine, lactate, or ammonia tests.
- Most diagnosed patients (20/24) had neurological or red flag signs; four boys had X-linked creatine transporter defect with speech-language delay.
Conclusions:
- Expanding first-tier metabolic testing to community pediatricians did not increase IEM diagnoses.
- A modified test panel is suggested for patients with GDD/ID and red flag signs.
- Urine creatine testing should be considered for boys with speech-language delay to detect creatine transporter defects.
Abstract:
Global developmental delay and intellectual disability (GDD/ID) affect 3% of the paediatric population. Although inborn errors of metabolism (IEM) are not a common cause of GDD/ID, early therapeutic intervention can improve neurodevelopmental manifestations. In 2012, a first-tier test panel, including specialized metabolic and routine chemistry tests, was piloted to community-based paediatricians in British Columbia with aims to achieve earlier diagnosis of treatable IEM.
Objective:
The aim of this retrospective review was to evaluate the diagnostic yield from these first-tier tests in the 7 years before (2006 to 2012) and after (2013 to 2019) implementation at the community paediatrician level.
Results:
Prior and postimplementation diagnostic yield of an IEM from first-tier metabolic testing was 9 out of 986 (0.91%) and 11 out of 4,345 children (0.25%), respectively. Disorders of creatine metabolism and organic acidurias were the most frequently established diagnoses in both time periods. No diagnoses were established through acylcarnitine copper/ceruloplasmin, lactate, or ammonia testing. Twenty out of 24 patients had specific neurological or other red flag signs in addition to GDD/ID. Four boys diagnosed with an x-linked creatine transporter defect (CTD) had speech-language delay as the most prominent finding.
Conclusions:
The expansion of first-tier metabolic testing to community-based paediatricians in BC did not yield an increase in IEM diagnoses. A modified first-tier test panel should be offered to patients with GDD/ID, neurologic, and/or red flag signs. Urine creatine testing in boys with speech-language delay warrants consideration to detect CTD.
Related Concept Videos
Intellectual Disability
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Inborn Errors of Metabolism
Binet's Contribution to Measures of Intelligence
Serum Laboratory Studies, Stool Test, Breath Test

